MIAMI, Jan. 29, 2025 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative .

The Aga Khan, known for his triumphs in horse racing, dazzling wealth and development work around the world, has died in ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

By prioritizing clarity, originality, online presence and research, your business name will capture the essence of your brand ...

The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...

Vanda Pharmaceuticals (VNDA) and AnaptysBio (ANAB) announced an exclusive, global license agreement for the development and commercialization of imsidolimab, which has successfully completed two ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, global license agreement for the development and commercialization of ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

MicroStrategy is changing its name to reflect its transformation from strictly a software firm to the self-described "world's ...

K. Ryan Jenkins was appointed executive director for business development at J&J Worldwide Services, a CBRE government and defense business. He brings extensive experience in base operational ...

“Being named one of Fortune’s World ... including each firm's effectiveness in conducting business globally, its ability to attract, develop, and keep talent, its value as a long-term ...

Vanda Logo (PRNewsfoto/Vanda Pharmaceuticals Inc.) GPP is a rare ... Imsidolimab has successfully concluded its development program in GPP, including the GEMINI-1 and GEMINI-2 global Phase 3 ...